Fostering regulatory collaboration to improve access to mpox…
International regulators have published a report highlighting their considerations on the development, clinical trials and availability of vaccines and therapeutics for mpox. The report presents the outcomes of a workshop that was organised by EMA under the umbrella of the International Coalition of Medicines Regulatory Authorities (ICMRA). In August 2024, the World Health Organisation (WHO) declared mpox […]
